Ahmed R N Ibrahim

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 4

Top Topics

Acute Lymphoblastic Leukemia

Prognostic Factors

Top Venues

Pharmaceuticals (Basel, Switzerland)

Medicina (Kaunas, Lithuania)

This page only lists publications with an associated author ORCID identifier.

Publications

Eman Mostafa Hamed, Ahmed R N Ibrahim, Mohamed Hussein Meabed, Ahmed M Khalaf, Doaa Mohamed El Demerdash, Marwa O Elgendy, Haitham Saeed, Heba F Salem, Hoda Rabea
Therapeutic Outcomes of High Dose-Dexamethasone versus Prednisolone + Azathioprine, Rituximab, Eltrombopag, and Romiplostim Strategies in Persistent, Chronic, Refractory, and Relapsed Immune Thrombocytopenia Patients. Pharmaceuticals (Basel, Switzerland) 16 (9) (2023)
Eman Mostafa Hamed, Mohamed Hussein Meabed, Ahmed R N Ibrahim, Ahmed M Khalaf, Doaa Mohamed El Demerdash, Marwa O Elgendy, Haitham Saeed, Tamer M Mahmoud, Heba F Salem, Hoda Rabea
Clinical Care Team's Guide for Awareness on Risk Assessment of Eltrombopag Complicating Acute Kidney Injury in Relapsed Immune Thrombocytopenic Patients: A Case Report. Medicina (Kaunas, Lithuania) 59 (9) (2023)
Eman Mostafa Hamed, Ahmed R N Ibrahim, Mohamed Hussein Meabed, Ahmed M Khalaf, Doaa Mohamed El Demerdash, Marwa O Elgendy, Haitham Saeed, Heba F Salem, Hoda Rabea
The Outcomes and Adverse Drug Patterns of Immunomodulators and Thrombopoietin Receptor Agonists in Primary Immune Thrombocytopenia Egyptian Patients with Hemorrhage Comorbidity. Pharmaceuticals (Basel, Switzerland) 16 (6) (2023)
Eman Mostafa Hamed, Ahmed R N Ibrahim, Mohamed Hussein Meabed, Ahmed M Khalaf, Doaa Mohamed El Demerdash, Marwa O Elgendy, Haitham Saeed, Heba F Salem, Hoda Rabea
The Outcomes and Adverse Drug Patterns of Immunomodulators and Thrombopoietin Receptor Agonists in Primary Immune Thrombocytopenia Egyptian Patients with Hemorrhage Comorbidity. Pharmaceuticals (Basel, Switzerland) 16 (6) (2023)